These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 35729616)
1. Epstein-Barr virus tegument protein BGLF2 in exosomes released from virus-producing cells facilitates de novo infection. Sato Y; Yaguchi M; Okuno Y; Ishimaru H; Sagou K; Ozaki S; Suzuki T; Inagaki T; Umeda M; Watanabe T; Fujimuro M; Murata T; Kimura H Cell Commun Signal; 2022 Jun; 20(1):95. PubMed ID: 35729616 [TBL] [Abstract][Full Text] [Related]
2. Suppression of JAK-STAT Signaling by Epstein-Barr Virus Tegument Protein BGLF2 through Recruitment of SHP1 Phosphatase and Promotion of STAT2 Degradation. Jangra S; Bharti A; Lui WY; Chaudhary V; Botelho MG; Yuen KS; Jin DY J Virol; 2021 Sep; 95(20):e0102721. PubMed ID: 34319780 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Suppresses Type I Interferon Signaling To Promote EBV Reactivation. Liu X; Sadaoka T; Krogmann T; Cohen JI J Virol; 2020 May; 94(11):. PubMed ID: 32213613 [TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Promotes EBV Reactivation through Activation of the p38 Mitogen-Activated Protein Kinase. Liu X; Cohen JI J Virol; 2016 Jan; 90(2):1129-38. PubMed ID: 26559845 [TBL] [Abstract][Full Text] [Related]
5. BGLF2 Increases Infectivity of Epstein-Barr Virus by Activating AP-1 upon Konishi N; Narita Y; Hijioka F; Masud HMAA; Sato Y; Kimura H; Murata T mSphere; 2018 Apr; 3(2):. PubMed ID: 29695622 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus tegument protein BGLF2 inhibits NF-κB activity by preventing p65 Ser536 phosphorylation. Chen T; Wang Y; Xu Z; Zou X; Wang P; Ou X; Li Y; Peng T; Chen D; Li M; Cai M FASEB J; 2019 Sep; 33(9):10563-10576. PubMed ID: 31337264 [TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr Virus BGLF2 commandeers RISC to interfere with cellular miRNA function. Campbell AM; De La Cruz-Herrera CF; Marcon E; Greenblatt J; Frappier L PLoS Pathog; 2022 Jan; 18(1):e1010235. PubMed ID: 35007297 [TBL] [Abstract][Full Text] [Related]
8. Modulation of B-cell exosome proteins by gamma herpesvirus infection. Meckes DG; Gunawardena HP; Dekroon RM; Heaton PR; Edwards RH; Ozgur S; Griffith JD; Damania B; Raab-Traub N Proc Natl Acad Sci U S A; 2013 Jul; 110(31):E2925-33. PubMed ID: 23818640 [TBL] [Abstract][Full Text] [Related]
9. Molecular Characterization of the Epstein-Barr Virus Chen T; Zou X; Xu Z; Wang Y; Wang P; Peng H; Liu D; Lin J; Luo R; Wang Y; Chen Q; Chen D; Cai M; Li M Iran J Biotechnol; 2018 May; 16(2):e1610. PubMed ID: 30805386 [TBL] [Abstract][Full Text] [Related]
10. Tegument proteins of Epstein-Barr virus: Diverse functions, complex networks, and oncogenesis. Murata T Tumour Virus Res; 2023 Jun; 15():200260. PubMed ID: 37169175 [TBL] [Abstract][Full Text] [Related]
11. Exosomes released in vitro from Epstein-Barr virus (EBV)-infected cells contain EBV-encoded latent phase mRNAs. Canitano A; Venturi G; Borghi M; Ammendolia MG; Fais S Cancer Lett; 2013 Sep; 337(2):193-9. PubMed ID: 23684926 [TBL] [Abstract][Full Text] [Related]
12. Cloning and characterization of cDNA clones corresponding to transcripts from the BamHI G region of the Epstein-Barr virus genome and expression of BGLF2. Chen MR; Hsu TY; Lin SW; Chen JY; Yang CS J Gen Virol; 1991 Dec; 72 ( Pt 12)():3047-55. PubMed ID: 1662696 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr Virus BKRF4 Gene Product Is Required for Efficient Progeny Production. Masud HMAA; Watanabe T; Yoshida M; Sato Y; Goshima F; Kimura H; Murata T J Virol; 2017 Dec; 91(23):. PubMed ID: 28904200 [TBL] [Abstract][Full Text] [Related]
15. Identification of herpesvirus proteins that contribute to G1/S arrest. Paladino P; Marcon E; Greenblatt J; Frappier L J Virol; 2014 Apr; 88(8):4480-92. PubMed ID: 24501404 [TBL] [Abstract][Full Text] [Related]
16. Viral miRNAs exploiting the endosomal-exosomal pathway for intercellular cross-talk and immune evasion. Pegtel DM; van de Garde MD; Middeldorp JM Biochim Biophys Acta; 2011; 1809(11-12):715-21. PubMed ID: 21855666 [TBL] [Abstract][Full Text] [Related]
17. Interaction Between BGLF2 and BBLF1 Is Required for the Efficient Production of Infectious Epstein-Barr Virus Particles. Hung CH; Chiu YF; Wang WH; Chen LW; Chang PJ; Huang TY; Lin YJ; Tsai WJ; Yang CC Front Microbiol; 2019; 10():3021. PubMed ID: 32038519 [TBL] [Abstract][Full Text] [Related]
18. TET2 functions as a resistance factor against DNA methylation acquisition during Epstein-Barr virus infection. Namba-Fukuyo H; Funata S; Matsusaka K; Fukuyo M; Rahmutulla B; Mano Y; Fukayama M; Aburatani H; Kaneda A Oncotarget; 2016 Dec; 7(49):81512-81526. PubMed ID: 27829228 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-encoded small RNAs (EBERs) are present in fractions related to exosomes released by EBV-transformed cells. Ahmed W; Philip PS; Tariq S; Khan G PLoS One; 2014; 9(6):e99163. PubMed ID: 24896633 [TBL] [Abstract][Full Text] [Related]
20. Functional Analysis of Exosomes Derived from EBV-Infected Cells. Khan G; Philip PS Methods Mol Biol; 2017; 1532():159-167. PubMed ID: 27873274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]